Artemis Therapeutics, Inc.

Research, Research, Biotechnology research
Founded in 2009
New York, New York
http://www.artemis-therapeutics.com
None

About Artemis Therapeutics, Inc.

Artemis Therapeutics, Inc. (ATMS) is a biopharmaceutical company developing novel treatments for serious and life-threatening infections. The company's lead drug candidate, Artemisone, is a best-in-class artemisinin which has been studied in a phase 2 clinical trial for the treatment of malaria (p. falciparum) and is currently undergoing in vitro evaluation for its activity against human cytomegalovirus (CMV), including transplant CMV and congenital CMV.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: None None
  • Last Funding: None None (None)
  • Funding Status: None

Technology Stack

Artemis Therapeutics, Inc. actively uses None products in their tech stack.

Market Presence

Industries: Research, Research, Biotechnology research

Headquarters: New York, New York